These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23974694)

  • 1. Newer targeted therapies in psoriasis.
    Khandpur S; Bhari N
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S47-52. PubMed ID: 23974694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental therapies for psoriasis.
    Asadullah K; Volk HD; Friedrich M; Sterry W
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):411-20. PubMed ID: 12546067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining clinical response in psoriasis: targeting the pathological basis of disease.
    Ortonne JP
    J Drugs Dermatol; 2004; 3(1):13-20. PubMed ID: 14964742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options in the treatment of psoriasis and atopic dermatitis.
    Gottlieb AB
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S3-16. PubMed ID: 15968262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term data in the treatment of psoriasis.
    Thaçi D
    Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of psoriasis: basic principles and new options].
    Vereecken P; Provost P; Willaert F; Heenen M; Bentin J
    Rev Med Brux; 2007 Sep; 28(4):336-44. PubMed ID: 17958030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cytokine therapy in the treatment of psoriasis.
    Kupetsky EA; Mathers AR; Ferris LK
    Cytokine; 2013 Mar; 61(3):704-12. PubMed ID: 23410503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pharmacological approaches in the treatment of psoriasis.
    Schleyer V; Landthaler M; Szeimies RM
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):1-20. PubMed ID: 15649186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
    Mudigonda P; Mudigonda T; Feneran AN; Alamdari HS; Sandoval L; Feldman SR
    Dermatol Online J; 2012 Oct; 18(10):1. PubMed ID: 23122008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF agents for the treatment of psoriasis.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2009 Jun; 8(6):546-59. PubMed ID: 19537380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor antagonists in the therapy of psoriasis.
    Mössner R; Schön MP; Reich K
    Clin Dermatol; 2008; 26(5):486-502. PubMed ID: 18755367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological treatments for moderate-to-severe psoriasis: indirect comparison.
    Galván-Banqueri M; Marín Gil R; Santos Ramos B; Bautista Paloma FJ
    J Clin Pharm Ther; 2013 Apr; 38(2):121-30. PubMed ID: 23442134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application.
    Ariza ME; Williams MV; Wong HK
    Clin Immunol; 2013 Feb; 146(2):131-9. PubMed ID: 23314273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of moderate-to-severe plaque psoriasis.
    Salgo R; Thaçi D
    G Ital Dermatol Venereol; 2009 Dec; 144(6):701-11. PubMed ID: 19907408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.
    Ortonne JP; Prinz JC
    Eur J Dermatol; 2004; 14(1):41-5. PubMed ID: 14965795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel immunotherapies for psoriasis.
    Asadullah K; Volk HD; Sterry W
    Trends Immunol; 2002 Jan; 23(1):47-53. PubMed ID: 11801454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.
    Myers WA; Gottlieb AB; Mease P
    Clin Dermatol; 2006; 24(5):438-47. PubMed ID: 16966023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and the new biologic agents: interrupting a T-AP dance.
    Walsh SR; Shear NH
    CMAJ; 2004 Jun; 170(13):1933-41. PubMed ID: 15210644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case presentation of moderate-severe psoriasis.
    Salmhofer W
    J Eur Acad Dermatol Venereol; 2012 Aug; 26 Suppl 5():19-20. PubMed ID: 22758914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.